Akash Saha

About

I completed my undergraduate studies in Biomedical Sciences (BSc Hons) at Queen Mary University of London, followed by postgraduate studies in Cancer Biology (MRes) at Imperial College London. Subsequently, I completed an additional Master's degree in Translational Immunology (MRes) as part of the Medical Research Council - Doctoral Training Programme (MRC-DTP).

Currently, I am a final year (MRC-DTP) PhD student under the supervision of Prof. Tyson Sharp at the Barts Cancer Institute, Queen Mary University of London. My PhD project focuses on validating a novel synthetic vulnerability in LIMD1 deficient lung cancers.

Employment

• Queen Mary University of London

Education

• Queen Mary University of London PhD in Cancer Biology
  2022 - 2025
• Queen Mary University of London MRes Translational Immunology, Distinction
  2021 - 2022
• Imperial College London MRes Cancer Biology, Distinction
  2020 - 2021
• Queen Mary University of London BSc Biomedical Sciences, First Class
  2017 - 2020

Projects & Funding

Projects & funding information is unavailable.

Publications (2)

• LIMD1 Loss Confers a GPX4-Dependent Cell State in Lung Cancer
  2025 DOI: 10.1101/2025.06.06.658274
  +Save
• The multifaceted role of micronuclei in tumour progression: A whole organism perspective.
  The International Journal of Biochemistry & Cell Biology 2022 DOI: 10.1016/j.biocel.2022.106300
  +Save